(Q52869506)
Statements
Radiolabeled hydroxamate-based matrix metalloproteinase inhibitors: How chemical modifications affect pharmacokinetics and metabolic stability. (English)
Verena Hugenberg
Sven Hermann
Fabian Galla
Michael Schäfers
Bernhard Wünsch
Katrin Szardenings
Joseph C Walsh
Vani P Mocharla
Umesh B Gangadharmath
17 March 2016